Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Organon & Co.
(NY:
OGN
)
20.35
+0.41 (+2.06%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organon & Co.
< Previous
1
2
3
4
5
6
7
8
Next >
3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio
November 19, 2021
Spin-off stocks can be lucrative for shareholders in both legacy businesses and recently created public companies. Here are three to know.
Via
InvestorPlace
Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3
November 18, 2021
Warren Buffett's Berkshire Hathaway Inc (NYSE: BRK-A) cleared its stake in Merck & Co Inc (NYSE: MRK) in Q3, right on the eve of a significant stock...
Via
Benzinga
Warren Buffet Takes A Stake In Royalty Pharma And Exits Merck — What You Need To Know
November 16, 2021
Warren Buffet's Berkshire Hathaway added more than 13 million shares.
Via
Investor's Business Daily
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care
November 12, 2021
Johnson & Johnson will split its consumer health unit into a publicly traded company.
Via
Investor's Business Daily
Earnings Scheduled For November 11, 2021
November 11, 2021
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape...
Via
Benzinga
Expert Ratings For Organon
October 07, 2021
Analysts have provided the following ratings for Organon (NYSE:OGN) within th...
Via
Benzinga
What 6 Analyst Ratings Have To Say About Organon
September 01, 2021
Organon (NYSE:OGN) has observed the following analyst ratings within the last...
Via
Benzinga
Veteran's Day
November 11, 2021
Stock markets took a tumble today across the board, but not as far down as at the opening.
Via
Talk Markets
Lower Sales Impact Organon's Q3 Margins; Acquires Forendo Pharma For Over $900M
November 11, 2021
Organon & Co (NYSE: OGN) has reported Q3 sales of $1.6 billion, down 1% Y/Y, slightly higher than the consensus of $1.58 billion. Women's Health declined...
Via
Benzinga
Organon Beat Quarterly Forecasts, Unveiled Takeover — Here's Why Shares Fell
November 11, 2021
Organon topped forecasts on Thursday and announced its plan to buy Forendo Pharma.
Via
Investor's Business Daily
Organon Reports Results for the Third Quarter Ended September 30, 2021
November 11, 2021
From
Organon & Co.
Via
Business Wire
Organon to Acquire Forendo Pharma
November 11, 2021
From
Organon & Co.
Via
Business Wire
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Why Merck's Strong Outlook For 2021 Could Become Even More Bullish
October 28, 2021
Merck issued upbeat guidance for 2021 that could grow if Covid pill molnupiravir gains authorization.
Via
Investor's Business Daily
Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021
October 28, 2021
From
Organon & Co.
Via
Business Wire
Europe's Unicorns
October 15, 2021
After markets jumped yesterday, we saw a lot of bounce today although gold fell back a bit.
Via
Talk Markets
Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women
October 15, 2021
From
Organon & Co.
Via
Business Wire
Organon Receives FDA Clearance for Technological Updates to the Jada® System, a Medical Device Intended to Control Postpartum Hemorrhage
October 11, 2021
From
Organon & Co.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
Upgrades For State Street Corporation (NYSE:
Via
Benzinga
Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy
September 21, 2021
From
Organon & Co.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021
September 01, 2021
Upgrades For Chatham Lodging Trust (NYSE:
Via
Benzinga
Organon To Present at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference
September 01, 2021
From
Organon & Co.
Via
Business Wire
Organon To Present at Citi’s 16th Annual BioPharma Virtual Conference
September 01, 2021
From
Organon & Co.
Via
Business Wire
Top Stocks Warren Buffett Just Bought
August 18, 2021
These were Berkshire Hathaway's biggest buys during Q2, 2021.
Via
The Motley Fool
Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
August 17, 2021
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and...
Via
Benzinga
Friday the Thirteenth
August 13, 2021
The stock week in points eastward was mixed. The USA markets face a bear correction.
Via
Talk Markets
Merck Spinoff Organon Just Reported Its First Quarter — Here's What You Need To Know
August 12, 2021
Organon crushed Wall Street's second-quarter expectations on Thursday and announced its first dividend, leading OGN stock to pop.
Via
Investor's Business Daily
Organon Reports Results for the Second Quarter Ended June 30, 2021 and Announces Inaugural Dividend
August 12, 2021
From
Organon & Co.
Via
Business Wire
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For August 12, 2021
August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.